Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × Temozolomide × Clear all

Sponsor

Conditions

Glioblastoma 104 Brain Neoplasms 50 Gliosarcoma 48 Glioma 42 Central Nervous System Neoplasms 28 Astrocytoma 27 Melanoma 21 Oligodendroglioma 14 Neuroblastoma 10 Neoplasm Metastasis 8 Ependymoma 7 Recurrence 6 Neoplasms 6 Sarcoma, Ewing 5 Lymphoma 5 Spinal Cord Neoplasms 4 Skin Neoplasms 4 Sarcoma 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Medulloblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Somatostatinoma 3 Gastrinoma 3 Colorectal Neoplasms 3 Carcinoma, Islet Cell 3 Uveal Melanoma 2 Rhabdomyosarcoma 2 Pinealoma 2 Pancreatic Neoplasms 2

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡